Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2861248 | 0.77 | ELANE (0.35) | ALDH1A1MAPK1L3MBTL1KMT2ALMNA | |
| SCHEMBL30937230 | 0.75 | ALDH1A1 (0.53) | ALDH1A1HCAR2TDP1MAPK1L3MBTL1 | |
| SCHEMBL4663055 | 0.75 | L3MBTL1 (0.50) | ALDH1A1TDP1L3MBTL1HTTTSHR | |
| SCHEMBL1109806 | 0.74 | TSHR (0.52) | ALDH1A1TDP1L3MBTL1CA1CA2 | |
| SCHEMBL13451270 | 0.73 | ALDH1A1 (0.59) | ALDH1A1HCAR2TDP1MAPK1L3MBTL1 | |
| SCHEMBL2859389 | 0.73 | ALDH1A1 (0.42) | ALDH1A1HCAR2TDP1MAPK1L3MBTL1 | |
| SCHEMBL2163834 | 0.73 | HDAC1 (0.59) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A3 | |
| SCHEMBL156493 | 0.73 | ALDH1A1 (0.63) | ALDH1A1HCAR2TDP1MAPK1L3MBTL1 | |
| SCHEMBL2162299 | 0.71 | MAPT (0.59) | ALDH1A1MAPK1L3MBTL1SLC6A3SMN1; SMN2 | |
| SCHEMBL2859462 | 0.71 | ALDH1A1 (0.32) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| CN-1972888-A | Method for producing ethers | KURARAY CO (JP) | 2007-05-30 | — | — | CN | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | ALDH1A1 3068/4885HCAR2 3428/4885TDP1 2332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.